Lessons Learned from the Pandemic 2023: Redesigning Clinical Care, Research, and Public Health

Now more than two years since the pandemic began, it is critically important to understand and learn what worked and what did not and assess these measures’ health, social, and economic impact worldwide. Understanding the strengths and weaknesses of these strategies, considering country-specific approaches, is essential to improve the preparedness for future variant-induced waves of infections and new pandemics. 

The COVID-19 pandemic brought innovations in public health, such as genomic surveillance, that could revolutionize the surveillance of pathogens for subsequent pandemics and epidemics. It also sparked a new wave of innovations across clinical care and research. The number of randomized clinical trials (RCTs) performed to evaluate COVID-19 therapeutics and vaccines is stunning and brought a wealth of data to inform clinical decision-making. There is an increased interest in the use of Real-World Evidence (RWE) to supplement RCT evidence and aid in clinical decision-making. Spurred by the pandemic, there is considerable innovation and growth in telemedicine. This tool was invaluable as a means of providing healthcare remotely during the lockdown, but it also highlighted equity issues for populations with limited Internet access. 

This workshop aimed to build on this foundation and design long-term solutions to strengthen epidemic preparedness globally. Briefly, this program aimed to gather different stakeholders to discuss, raise awareness, synthesize knowledge on the lessons learned from the COVID-19 pandemic, and rethink clinical care and research through the exchange of scientific evidence from the COVID-19 pandemic.

The program gathered public (health) authorities, epidemiologists, economists, (clinical) scientists, clinicians, and other healthcare professionals to make knowledge available to policymakers worldwide and to design long-term and durable solutions for future pandemics, clinical care, and research.

General Information 

Practical Information 

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

To augment the organizing committee, the following are scientific committee members

• Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc HonLLD Monash, DPMP - President and Pro Vice Chancellor, Monash University, Malaysia

• Elliot Raizes, MD - CDC, United States

• Antoine Flahault, MD, PhD - Director of the Institute of Global Health, Faculty of Medicine, University of Geneva

• Helena Legido-Quigley, PhD - National University of Singapore

• Michel Goldman, MD, PhD - University of Brussels

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Moderna has provided funding for this Independent Medical Education program.

Moderna has had no input into the selection of speakers or the content of the materials and presentations.

Lessons Learned from the Pandemic 2023: Redesigning Clinical Care, Research, and Public Health is endorsed by the following societies and organizations. Their support and collaboration are key to the success of this program!

If you would like your organization to endorse this meeting, please contact Vicky Cheng at vicky.cheng@amededu.com or Gigi Lam at gigi.lam@amededu.com.